Research & Reviews: Journal of Computational Biology
Open Access
Subscription or Fee Access
Molecular Docking Analysis of Punica granatum Compounds as Potential Inhibitors for Colorectal Cancer-Associated Molecular Targets
Abstract
Objective: Cancer is one of the most common worldwide disease which threat the life of a person. Colorectal cancer is one of the common cause of death nowadays. As computation approach is now employed for new drug discovery, target protiens like CDK-2, matrix metalloproteinase 2 (MMP-2), cyclin A, poly (ADP- ribose) polymerase (PARP-1) and Cox2 were chosen to perform molecular docking against the derivatives of Punica granatum phtyochemicals and Food and Drug Administration (FDA) approved drugs. Its pharmacological characteristics and therapeutic analysis were investigated.
Methods: In this study, 30 derivatives of Punica granatum was used to assess their binding affinity towards the target proteins ( CDK-2, MMP-2, cylin A, PARP-1 and Cox-2). By using the virtual tool, PyRx, molecular docking was performed. The investigation was carried out computationally, also obtained molecular structures of the phytochemicals and proteins from Indian medicinal plants, phytochemistry and therapeutics, and PubChem. The proteins were purified using BIOVIA Discovery Studio Software and PDBsum generate. The pharmacological assessment of the ligands was performed by using ADMETlab 2.0.
Result: As per the result of molecular docking, the ligand maslinic acid, betulinic acid, friedelin and granatin B were found to have the best binding affinity towards the five target proteins.
Conclusion: It was seen that the plant derived phytochemicals have better binding affinity as compared to the FDA approved drugs, so it can be considered as a better approach for drug discovery. However, in vitro research is still required to support these findings.
Keywords
References
Macharia JM, Mwangi RW, Rozmann N, Zsolt K, Varjas T, Uchechukwu PO, Wagara IN, Raposa BL. Medicinal plants with anti-colorectal cancer bioactive compounds: Potential game-changers in colorectal cancer management. Biomedicine & Pharmacotherapy. 2022 Sep 1;153:113383.
Granados-Romero JJ, Valderrama-Treviño AI, Contreras-Flores EH, Barrera-Mera B, Herrera Enríquez M, Uriarte-Ruíz K, Ceballos-Villalba JC, Estrada-Mata AG, Alvarado Rodríguez C, Arauz-Peña G. Colorectal cancer: a review. Int J Res Med Sci. 2017 Oct;5(11):4667.
Saif, M. W., & Chu, E. Biology of colorectal cancer. The Cancer Journal, 2010);16(3), 196-201.
Iacopetta, B. Are there two sides to colorectal cancer?. International journal of cancer, 2002; 101(5), 403-408.
Walsh, J. M., & Terdiman, J. P.. Colorectal cancer screening: scientific review. Jama, 2003;289(10), 1288-1296.
Simon, K.. Colorectal cancer development and advances in screening. Clinical interventions in aging, 201611, 967.
Wolpin, B. M., & Mayer, R. J. Systemic treatment of colorectal cancer. Gastroenterology, 2008;134(5), 1296-1310.
Prashanth, D., Asha, M. K., & Amit, A. Antibacterial activity of Punica granatum. Fitoterapia, 2001; 72(2), 171-173.
Arun, N., & Singh, D. P. Punica granatum: a review on pharmacological and therapeutic properties. International journal of pharmaceutical sciences and research, 2012; 3(5), 1240.
Akbarpour, V., Hemmati, K., & Sharifani, M. Physical and chemical properties of pomegranate (Punica granatum L.) fruit in maturation stage. American-Eurasian Journal of Agricultural & Environmental Sciences, 2009;6(4), 411-416.
Benarba, B., & Pandiella, A. Colorectal cancer and medicinal plants: Principle findings from recent studies. Biomedicine & Pharmacotherapy, 2018;107, 408-423.
Molassiotis, A., Fernandez-Ortega, P., Pud, D., Ozden, G., Platin, N., Hummerston, S., ... & Kearney, N. Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complementary therapies in medicine, 2005;13(4), 251-257.
Huang, X. M., Yang, Z. J., Xie, Q., Zhang, Z. K., Zhang, H., & Ma, J. Y. Natural products for treating colorectal cancer: A mechanistic review. Biomedicine & Pharmacotherapy, 2019;117, 109142.
Tanaka, T., Tanaka, M., Tanaka, T., & Ishigamori, R. Biomarkers for colorectal cancer. International journal of molecular sciences, 2010;11(9), 3209-3225.
Shaker, B., Ahmad, S., Lee, J., Jung, C., & Na, D. In silico methods and tools for drug discovery. Computers in biology and medicine, 2021;137, 104851.
Butina, D., Segall, M. D., & Frankcombe, K. Predicting ADME properties in silico: methods and models. Drug discovery today, 2002; 7(11), S83-S88.
Valero-Mendoza, A. G., Meléndez-Rentería, N. P., Chávez-González, M. L., Flores-Gallegos, A. C., Wong-Paz, J. E., Govea-Salas, M., ... & Ascacio-Valdés, J. A. The whole pomegranate (Punica granatum. L), biological properties and important findings: A review. Food Chemistry Advances, 2022;100153.
Advani, S., & Kopetz, S. Ongoing and future directions in the management of metastatic colorectal cancer: Update on clinical trials. Journal of surgical oncology, 2019; 119(5), 642-652.
Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol [Internet]. 2015;1263:243–50.
Fujita, K. I., Kubota, Y., Ishida, H., & Sasaki, Y. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World journal of gastroenterology, 2015; 21(43), 12234.
Bhowmik, D., Gopinath, H., Kumar, B. P., & Kumar, K. S. Medicinal uses of Punica granatum and its health benefits. Journal of Pharmacognosy and phytochemistry, 2013;1(5), 28-35.
Huang, L., Guan, T., Qian, Y., Huang, M., Tang, X., Li, Y., & Sun, H. Anti-inflammatory effects of maslinic acid, a natural triterpene, in cultured cortical astrocytes via suppression of nuclear factor-kappa B. European journal of pharmacology, 2011;672(1-3), 169-174.
Yap, W. H., & Lim, Y. M. . Mechanistic perspectives of maslinic acid in targeting inflammation. Biochemistry research international, 2015.
Li, C., Yang, Z., Zhai, C., Qiu, W., Li, D., Yi, Z., ... & Liu, M. Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway. Molecular cancer, 2010; 9(1), 1-13.
Fuentes-Rios, D., Cepero, A., García-Castro, M., Contreras-Cáceres, R., López-Romero, J. M., Luque, C., ... & Prados, J. Synthesis, solubility and antitumor activity of maslinic acid derivatives. European Journal of Medicinal Chemistry Reports, 2022; 4, 100032.
Qian, X. P., Zhang, X. H., Sun, L. N., Xing, W. F., Wang, Y., Sun, S. Y., ... & Wang, Y. Q. Corosolic acid and its structural analogs: A systematic review of their biological activities and underlying mechanism of action. Phytomedicine, 2021; 91, 153696.
Koosha, S., Alshawsh, M. A., Looi, C. Y., Seyedan, A., & Mohamed, Z. An association map on the effect of flavonoids on the signaling pathways in colorectal cancer. International journal of medical sciences, 2016;13(5), 374.
Sayers EW, Beck J, Bolton EE, Bourexis D, Brister JR, Canese K, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res [Internet]. 2021;49(D1):D10–7.
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. Nucleic Acids Res [Internet]. 2000;28(1):235–42:
Panikar S, Shoba G, Arun M, Sahayarayan JJ, Usha Raja Nanthini A, Chinnathambi A, et al. Essential oils as an effective alternative for the treatment of COVID-19: Molecular interaction analysis of protease (Mpro) with pharmacokinetics and toxicological properties. J Infect Public Health 2021;14(5):601–10.
Refbacks
- There are currently no refbacks.